Psychological burden and resilience factors in patients with Alveolar Echinococcosis - A cross-sectional study.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
30
08
2018
accepted:
15
12
2018
revised:
17
01
2019
pubmed:
8
1
2019
medline:
12
2
2019
entrez:
8
1
2019
Statut:
epublish
Résumé
Alveolar echinococcosis (AE) is a parasitic zoonosis resembling malignancy due to its clinically silent infiltrative growth, predominately in the liver. The comorbid psychological burden and fear of disease progression in AE patients have hardly been examined to date. The aim of this study was to evaluate depression, anxiety, quality of life, and fear of disease progression in AE patients. In a cross-sectional study, n = 57 AE patients were invited to report on depression (PHQ-9), anxiety (GAD-7), somatic symptom load (SSS 8), trauma symptoms (PTSS-10), quality of life (SF-12) and on fear of disease progression (FoP-Q-SF) using validated psychometric instruments. Furthermore, attachment style was assessed (RQ-2). N = 47 patients completed the questionnaires (response rate 82.5%). Depression, anxiety, and somatic symptom load were above norm sample means, while physical quality of life was below norm sample means. Existing traumatic symptoms were comparable to those in cancer patients, while fear of disease progression even exceeded cancer patient scores. Patients with a secure attachment style showed less pronounced psychological burden than patients with other attachment styles. Adequate, guideline-based depression and anxiety treatment was very rarely installed. The present study revealed remarkable levels of psychological burden in AE patients. In our study sample, we discovered high depression and anxiety levels, a significant reduction of physical quality of life, and fear of disease progression. These results show how important it is for AE patients to be thoroughly assessed with regard to psychological symptoms and mental disorders so that those in need can receive sufficient psychosocial support and treatment according to official guidelines.
Sections du résumé
BACKGROUND
Alveolar echinococcosis (AE) is a parasitic zoonosis resembling malignancy due to its clinically silent infiltrative growth, predominately in the liver. The comorbid psychological burden and fear of disease progression in AE patients have hardly been examined to date. The aim of this study was to evaluate depression, anxiety, quality of life, and fear of disease progression in AE patients.
METHODOLOGY/PRINCIPAL FINDINGS
In a cross-sectional study, n = 57 AE patients were invited to report on depression (PHQ-9), anxiety (GAD-7), somatic symptom load (SSS 8), trauma symptoms (PTSS-10), quality of life (SF-12) and on fear of disease progression (FoP-Q-SF) using validated psychometric instruments. Furthermore, attachment style was assessed (RQ-2). N = 47 patients completed the questionnaires (response rate 82.5%). Depression, anxiety, and somatic symptom load were above norm sample means, while physical quality of life was below norm sample means. Existing traumatic symptoms were comparable to those in cancer patients, while fear of disease progression even exceeded cancer patient scores. Patients with a secure attachment style showed less pronounced psychological burden than patients with other attachment styles. Adequate, guideline-based depression and anxiety treatment was very rarely installed.
CONCLUSION/SIGNIFICANCE
The present study revealed remarkable levels of psychological burden in AE patients. In our study sample, we discovered high depression and anxiety levels, a significant reduction of physical quality of life, and fear of disease progression. These results show how important it is for AE patients to be thoroughly assessed with regard to psychological symptoms and mental disorders so that those in need can receive sufficient psychosocial support and treatment according to official guidelines.
Identifiants
pubmed: 30615695
doi: 10.1371/journal.pntd.0007082
pii: PNTD-D-18-01255
pmc: PMC6336346
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0007082Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
J Affect Disord. 2016 Nov 01;204:146-53
pubmed: 27344624
J Affect Disord. 2004 Oct 15;82(2):271-6
pubmed: 15488257
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Psychopathology. 2017;50(4):262-272
pubmed: 28704829
BMJ. 2006 Apr 29;332(7548):985-6
pubmed: 16644810
J Psychosom Res. 2016 Sep;88:1-7
pubmed: 27521644
J Affect Disord. 2017 Mar 15;211:44-59
pubmed: 28088057
BMJ Open Gastroenterol. 2015 Jul 16;2(1):e000036
pubmed: 26462284
Psychol Bull. 2011 Jan;137(1):19-46
pubmed: 21219056
J Anxiety Disord. 2015 Oct;35:103-17
pubmed: 26409250
PLoS One. 2015 Jun 19;10(6):e0130973
pubmed: 26091101
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Jan;54(1):120-7
pubmed: 21246337
Dialogues Clin Neurosci. 2015 Sep;17(3):327-35
pubmed: 26487813
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Eur J Heart Fail. 2005 Mar 2;7(2):261-7
pubmed: 15701476
Int J Cardiol. 2013 Jul 31;167(2):502-7
pubmed: 22341693
Arch Gen Psychiatry. 2005 Dec;62(12):1313-20
pubmed: 16330719
PLoS Med. 2013 Nov;10(11):e1001547
pubmed: 24223526
J Affect Disord. 2018 Aug 15;236:274-290
pubmed: 29751243
BMJ. 2012 Jul 31;345:e4933
pubmed: 22849956
Br J Psychiatry. 2007 Apr;190:326-32
pubmed: 17401039
JAMA Intern Med. 2014 Mar;174(3):399-407
pubmed: 24276929
Recent Results Cancer Res. 2014;197:11-29
pubmed: 24305766
Acta Trop. 2010 Apr;114(1):1-16
pubmed: 19931502
Onkologie. 2013;36(10):540-4
pubmed: 24107906
Z Psychosom Med Psychother. 2006;52(3):274-88
pubmed: 17156600
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
J Psychosom Res. 2005 Jun;58(6):505-11
pubmed: 16125517
Diabetes Care. 2016 Dec;39(12):2182-2189
pubmed: 27797932
J Affect Disord. 2017 Oct 15;221:36-46
pubmed: 28628766
JAMA Intern Med. 2013 Jan 14;173(1):22-7
pubmed: 23212347
J Psychosom Res. 2015 Jun;78(6):569-72
pubmed: 25770643
Encephale. 2009 Dec;35 Suppl 7:S269-71
pubmed: 20141785
Diabetes Care. 2002 Mar;25(3):464-70
pubmed: 11874931
J Pers Soc Psychol. 1991 Aug;61(2):226-44
pubmed: 1920064
Infection. 2019 Feb;47(1):67-75
pubmed: 30225656
Psychosom Med. 2004 May-Jun;66(3):395-402
pubmed: 15184703
Mol Psychiatry. 2009 Jul;14(7):728-37
pubmed: 18283278
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941